Cargando…
A case with Gaucher disease unable to reach enzyme replacement therapy because of COVID-19 quarantine: The first case from Turkey
Autores principales: | Yekedüz, Merve Koç, Köse, Engin, Eminoğlu, Fatma Tuba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Pediatric Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152655/ https://www.ncbi.nlm.nih.gov/pubmed/34104921 http://dx.doi.org/10.5152/TurkArchPediatr.2021.21023 |
Ejemplares similares
-
Delayed Diagnosis of Cobalamin E Defect in an Adolescent Patient
por: Yekedüz, Merve Koç, et al.
Publicado: (2020) -
Unmet Needs of Children with Inherited Metabolic Disorders in the COVID-19 Pandemic
por: Özalp Akın, Ezgi, et al.
Publicado: (2022) -
Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders
por: Eminoğlu, Fatma Tuba, et al.
Publicado: (2021) -
Cross-Cultural Differences in Stigma Associated with Parkinson’s Disease: A Systematic Review
por: Karacan, Ahmet Veli, et al.
Publicado: (2023) -
Mental health considerations for children quarantined because of COVID-19
por: Liu, Jia Jia, et al.
Publicado: (2020)